JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
Favorable safety and tolerability profile, with rapid onset of clinical [...]
Favorable safety and tolerability profile, with rapid onset of clinical [...]
Novo Nordisk launches Wegovy® pill in the United Arab Emirates [...]
“By integrating Oxford Nanopore’s direct RNA sequencing into Lonza’s QC [...]
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform [...]
This evolution formalizes Mopec Group’s commitment to developing integrated, technology-driven [...]
Connects scientific teams, data and workflows within a single, fully [...]
UK Biotech Day 2026 is designed to spark meaningful conversations, [...]
Ambient-temperature preservation solution enables reliable storage and shipment of organoids [...]
As the pace of biotechnology research accelerates, companies are increasingly [...]
Variational AI introduces Enki 4: an improved algorithm and architecture [...]